High-content analysis (HCA) or high-content screening (HCS) defines a set of programmed diagnostic methods using integrated microscopy, image processing, and visualization gears to mine data from cells or cell populations and report quantitative results. Over the past five years, a majority of HTS laboratories have adopted high-content screening (HCS) in their operations. As HTS laboratories have sought more biologically-relevant assays, cell-based assays, and high content screening technologies have become more widespread. More than three-quarters of the academic laboratories have implemented HCS technologies, while to some extent over half of the pharma/biotech HTS laboratories use HCS technologies in their high throughput screening operations. While a bulk of academic institutes and pharma/biotech firms have implemented some HCS technologies, a small section of contract research organizations uses HCS technologies. Approximately, one-quarter of the contract research organizations use HCS technologies in their laboratories.
Rapid technological advances, increased government spending & private investments, increased adoption of high-content screening and product innovations are the major drivers of the high content screening market.
Expensive equipment and lack of properly skilled labor are the major restraints faced by the market.
The global high content screening market can be segmented by -
Geographically, the global high content screening is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and Latin America. Currently, North America is the largest market for high content screening, which can be attributed to the increasing incidence of chronic diseases, various collaborations with research institutes and partnerships among the major players for developing and marketing new products.
Market analysis for the global high content screening market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers, restraints opportunities and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the global high content screening market.
Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped.
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
1.7 Report Description
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
3. Executive Summary
4. Key Inferences
5. Market Characterization
5.1 Current Market Scenario
5.2 Market Overview
5.3 Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis
5.3.1 Market Drivers
22.214.171.124 Rapid Technological Advances
126.96.36.199 Increase in The Government Spending and Private Investments
188.8.131.52 Increased Adoption of High Content Screening
184.108.40.206 Product Innovations
5.3.2 Market Restraints
220.127.116.11 Expensive Equipment Hinder the Growth of The Market
18.104.22.168 Lack of Proper Skilled Labor
6. Market Segmentation
6.1 By Product
6.1.1 Segmentation Tools
22.214.171.124 Nuclear Masks
126.96.36.199 Cell Masks
188.8.131.52 Imaging Stains
184.108.40.206 Cell Tracking and Tracing Tools
220.127.116.11 Plasma Membrane Masks
18.104.22.168 Plasma Membrane Stains
22.214.171.124 Cell Structure Stains
6.2 By Application
6.2.1 Explorative Screening
6.2.2 Cell Signaling
6.2.5 Target Validation
6.2.7 Compound Profiling
6.3 By End-User
6.4 By Geography
6.4.1 North America
126.96.36.199 Rest of Europe
188.8.131.52 South Korea
184.108.40.206 Rest of Asia-Pacific
6.4.4 The Middle East and Africa
220.127.116.11 South Africa
6.4.5 Latin America
7. Industry Analysis
7.1 Porterâ€™s Five Forces
7.1.1 Bargaining Power of Suppliers
7.1.2 Bargaining Power of Consumers
7.1.3 Threat of New Entrants
7.1.4 Threat of Substitute Products and Services
7.1.5 Competitive Rivalry within the Industry
8. Competitive Landscape
8.1 Mergers & Acquisitions
8.2 Agreements, Collaborations & Partnerships
8.3 New Product Launches
8.4 Recommendations to new market players
9. Company Profiles
9.1 Becton Dickinson
9.2 Danaher Corporation
9.3 GE Healthcare
9.5 Life Technologies
9.7 Yokogawa Electric Corporation
9.8 Thermo Fisher Scientific
9.9 Genedata AG
9.10 Cell Signaling Technologies
10. Future Outlook